![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||
|
I have been a patient with this condition for the past year, so I would like to update the article a little, particularly to help the newly diagnosed. Firstly, I would like to change the name of the condition, as it is now more commonly known in medical and patient circles as ALK positive non-small cell lung cancer (or just ALK positive lung cancer for short). Whilst EML4 is, by far, the most common fusion partner for this condition, there are rarer fusion partners, which this article seems to ignore - perhaps those other fusion partners were not apparent when the article was originally written. I would also like to add that the median age of diagnosis is around 50, that it is more common in women and some other information that is now available, which perhaps was not several years ago. Of course, I will make the scientific references available, although much will come from the paper that I have already uploaded from Dr Sai-Hong Ignatious Ou, who is one of the world's leading experts. Shaun p hill ( talk) 23:34, 31 January 2023 (UTC)
![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||
|
I have been a patient with this condition for the past year, so I would like to update the article a little, particularly to help the newly diagnosed. Firstly, I would like to change the name of the condition, as it is now more commonly known in medical and patient circles as ALK positive non-small cell lung cancer (or just ALK positive lung cancer for short). Whilst EML4 is, by far, the most common fusion partner for this condition, there are rarer fusion partners, which this article seems to ignore - perhaps those other fusion partners were not apparent when the article was originally written. I would also like to add that the median age of diagnosis is around 50, that it is more common in women and some other information that is now available, which perhaps was not several years ago. Of course, I will make the scientific references available, although much will come from the paper that I have already uploaded from Dr Sai-Hong Ignatious Ou, who is one of the world's leading experts. Shaun p hill ( talk) 23:34, 31 January 2023 (UTC)